Cargando…
MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management
MYC, a potent oncogene located at chromosome locus 8q24.21, was identified initially by its involvement in Burkitt lymphoma with t(8;14)(q24;q32). MYC encodes a helix-loop-helix transcription factor that accentuates many cellular functions including proliferation, growth and apoptosis. MYC alteratio...
Autores principales: | Cai, Qingqing, Medeiros, L. Jeffrey, Xu, Xiaolu, Young, Ken H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770723/ https://www.ncbi.nlm.nih.gov/pubmed/26416427 |
Ejemplares similares
-
MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas
por: Aquino, Gabriella, et al.
Publicado: (2013) -
Epigenetics, c-Myc and Aggressive B-cell Lymphomas
por: Zhang, Yizhuo, et al.
Publicado: (2012) -
Integrative genomic analysis focused on cell cycle genes for MYC-driven
aggressive mature B-cell lymphoma
por: Yamashita, Takahisa, et al.
Publicado: (2020) -
EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management
por: Ok, Chi Young, et al.
Publicado: (2015) -
The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock
por: West, A C, et al.
Publicado: (2016)